务实测量不确定度:使室内质控数据时长与长期监测的临床现实对齐
ISO 15189:2022要求医学实验室评估测量不确定度(MU),ISO/TS 20914:2019建议用6至12个月室内质控(IQC)数据推导实验室内复现性标准不确定度(uRw)。本文指出对用于长期监测的分析物(如甲状腺球蛋白、PSA、肌酐/eGFR等),该数据窗口应覆盖检测的临床应用窗口,并建议采用两阶段方案:滚动年度uRw用于分析趋势,汇总长期uRw用于临床报告。
要点
- 长期监测分析物的uRw数据时长应匹配其临床应用窗口。
- 个体指数可识别短期uRw不足影响最大的分析物,解释基于参考变化值。
- 按试剂和质控批号分区可保持长期uRw估计的可靠性。
核心结论
- 建议将IQC数据时长与检测的临床应用窗口对齐,从理想化短期精密度转向务实、临床适用的MU。
研究设计与样本
- 本文为致编辑信/观点文章,未报告研究设计与样本。
主要发现
- 对长期监测分析物,2021年结果可能与2026年结果比较,相关不确定度跨度应覆盖该 interval 内所有试剂和校准品批号、再校准及维护事件。
- 个体指数可识别短期uRw不足影响最大的分析物,解释基于参考变化值。
关键数值与推荐
- ISO 15189:2022要求实验室估计MU;ISO/TS 20914:2019提供自上而下方法,uRw通常源自6至12个月IQC数据。
- CLSI C24和ISO/TS 20914建议按试剂和质控批号分区以保持长期估计可靠。
- 推荐两阶段方案:滚动年度uRw用于分析趋势,汇总长期uRw用于临床报告。
临床怎么用
- 对长期监测分析物,应采用覆盖临床应用窗口的长期uRw进行临床报告,并用滚动年度uRw监测分析趋势。
局限性
- 本文为观点文章,未提供原始研究数据或验证结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ISO 15189:2022 requires medical laboratories to estimate measurement uncertainty (MU), and ISO/TS 20914:2019 provides the practical guidance for doing so, typically through a top-down approach in which the within-laboratory reproducibility standard uncertainty (uRw) is derived from 6 to 12 months of internal quality control (IQC) data. This criterion is defined by the routine sources of variation captured, not by the window over which results are actually compared. For acute, single-use tests the two coincide; for analytes used in long-term monitoring - thyroglobulin, PSA, creatinine/eGFR, and many tumor markers and endocrine parameters - a result from 2021 may be compared with one from 2026, and the relevant uncertainty spans every reagent and calibrator lot, recalibration and maintenance event within that interval, whatever the analyte. Where a valid estimate of within-subject biological variation is available, the index of individuality identifies the analytes for which this shortfall matters most, interpretation then resting on the reference change value. This letter proposes aligning the duration of IQC data with the clinical application window of the test. Partitioning by reagent and QC lot, as recommended by CLSI C24 and ISO/TS 20914, keeps long-term estimates sound. This perspective extends the "Measurement Uncertainty for Practical Use" (MUPU) model to the temporal axis, advocating a shift from idealised short-term precision to pragmatic, clinically fit-for-purpose MU. A two-stage scheme is recommended: a rolling annual uRw for analytical trends and an aggregate long-term uRw for clinical reporting. Future guideline revisions should individualise the uRw duration according to the clinical use window of the test.
引用
- Yurt EF. Pragmatic measurement uncertainty: Aligning IQC data duration with clinical reality in long-term monitoring. Clin Chim Acta. 2026. PMID: 42532314. doi:10.1016/j.cca.2026.121246
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。